Media Room
16 July 2024
Pr. Vincent Lebon
“Thanks to this unique Lemer Pax equipment, the SHFJ is able to produce radiopharmaceuticals for medical research with a high degree of reliability. These radiopharmaceuticals are used to carry out molecular imaging clinical trials at the SHFJ, as well as...
3 July 2024
Lemer Pax, sponsor of the WASZP 2024 French Championship
From 4 to 7 July, the Yacht Club de la Grande Motte (France), in partnership with the Centre d’Entraînement Méditerranée, will be hosting the French championship for Waszp, the new foiling flying dinghy. Another innovation, and a world first in...
27 June 2024
RadioPharmaceutical Therapy (RPT): a major advance in cancer treatment
RadioPharmaceutical Therapy (RPT) represents a significant advance in the fight against cancer. Although this innovative technique currently accounts for only a small proportion of cancer treatments, RPT offers new perspectives for treating malignant tumours by precisely targeting cancer cells while...
27 May 2024
Signe Reinholdt Sørensen
“If we compare with the automatic injector that we had before, the members of the medical team are now much less exposed to radiation. Indeed, in the past, we had to manually dilute all the doses of tracer received every...
24 April 2024
Lemer Pax signs a partnership for distributing ICUMedical’s Plum 360™ pump for the french nuclear medicine market
On 1 January 2024, Lemer Pax, world leader in innovation in the field of radiation protection, and ICU Medical, world leader in infusion systems, infusion consumables and intensive care products, signed a partnership for distributing the Plum 360TM pump for...
27 February 2024
Better understanding, prediction and treatment of cancers and neurodegenerative diseases: the example of the Frédéric Joliot Hospital in Orsay
Better understanding, prediction and treatment of cancers and neurodegenerative diseases. This is the main mission of the CEA, Frédéric Joliot Hospital Department (SHFJ), through its pioneering nuclear medicine department and its BioMaps (Multimodal Biomedical Imaging Paris-Saclay), located within the Orsay...
31 January 2024
2023 Retrospective
Ongoing projects, success stories, technological innovations, events and business news… our interactive retrospective takes a look back at the highlights of the past year! Once again, the Lemer Pax teams wish you all the best for 2024! [INSTRUCTIONS] You can navigate...
19 December 2023
Lemer Pax and SNOLAB: Act II before the underground installation
In late December 2019, Lemer Pax delivered an ultra-low background noise shielding structure to the Canadien Super CDMS (Super Cryogenic Dark Matter Search) Snolab project. The scientific focus of this project revolves around astroparticle physics, particularly neutrinos and dark matter....
14 November 2023
Nuclear fusion, the example of ITER
ITER (International Thermonuclear Experimental Reactor, also meaning "path" in Latin) is a scientific programme and challenge. Its aim is to carry out controlled nuclear fusion experiments at unprecedented levels of power and duration, and to understand the dynamics involved.
Due to its size, the ITER tokamak will be the most powerful tokamak ever built.
To achieve this objective, it will be necessary to create neutron-absorbing materials in the mortar family: lightweight and hydrogen-rich.
10 October 2023
3 questions for … Cécile Arbouille, Senior Executive Advisor, Nuclear Generation Division / EDF
We asked Cécile Arbouille, Delegate to the Nuclear Generation Division at EDF, 3 questions. In charge of Industrial Policy and Supplier Relations, she has a central role to play in the challenge of ensuring the secure, available and cost-effective operation of France’s fleet of nuclear power plants.
8 September 2023
1st Lutetium-177 injections with the Theranojet®ARA shielded injection system at the Beaujon AP-HP hospital, Paris, France
On August 3, the Beaujon AP-HP hospital Nuclear Medicine department AP-HP (Assistance Publique – Hôpitaux de Paris), located in Clichy, in Paris (France), successfully injected its first treatments with Lutathera using the new Theranojet®ARA shielded injection system. The result of...
26 August 2023
Lemer Pax launches OSIRIS, its Lean management transformation with EliteOrga
In a context of major growth for the company, particularly in a field of activity requiring a large dose of rigour and organization, Lemer Pax decided in 2019 to start, with EliteOrga, a major organizational transformation project. These important developments,...
31 July 2023
Stephan Dewarrat
"Swiss regulations in radiation protection are such that Posijet®, the unit for preparation and automatic injection, turned out to be the best solution."
15 June 2023
Lemer Pax and CCNuclear announce the creation of Lemer Pax America
The creation of the Canadian company Lemer Pax America will be officially announced at the 35th edition of the SNMMI (Society of Nuclear Medicine & Molecular Imaging) in Chicago on June 24-27 by Pierre-Marie Lemer, President of Lemer Pax, and...
11 May 2023
Denis Brault
"All the restrictions made us choose the Posijet® automatic injector. Personally, I’m very pleased with it. Lemer Pax’s training and support have been excellent. The remote familiarisation feature is an added bonus for us, making us more responsive, which we really needed to be. The regular software updates also make it easy to use. "
27 April 2023
The Radiation Protection Advisor (RPA)
The immanente guarantee of radiation protection
By anticipating the risks of exposure to ionizing radiation, the Radiation Protection Advisor (RPA) applies the safety rules defined by the Labour Code and the Public Health Code and implements the means to guarantee optimal radiation protection (ALARA principle). Here at Lemer Pax, the Radiation Protection Advisor intervenes in all areas related to radiation protection (medical, industry, etc.) and brings their expertise to the development of the innovative equipment of tomorrow.